(Q13896859)

DrugBank

image of molecular model or crystal lattice model

17 November 2015

Pembrolizumab 5DK3.png
2,048 × 2,048; 211 KB

depicts

space-filling model

1 reference

imported from Wikimedia project

Russian Wikipedia

Wikimedia import URL

https://ru.wikipedia.org/?oldid=107323917

mass

149,000 dalton

1 reference

1 reference

European Medicines Agency product number

EMEA/H/C/003820

reference URL

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003820/human_med_001886.jsp

World Health Organisation international non-proprietary name

22 March 2017

pembrolizumab (English)

0 references

medical condition treated

colon cancer

1 reference

transitional cell carcinoma

2 October 2018

1 reference

tongue squamous cell carcinoma

2 October 2018

1 reference

2 October 2018

melanoma

1 reference

2 October 2018

bladder cancer

1 reference

2 October 2018

Merkel cell carcinoma

1 reference

head and neck squamous cell carcinoma

2 October 2018

1 reference

bladder urothelial carcinoma

2 October 2018

1 reference

2 October 2018

renal cell carcinoma

1 reference

non-small-cell lung carcinoma

2 October 2018

1 reference

2 October 2018

benign mesothelioma

1 reference

squamous cell carcinoma of the lung

2 October 2018

1 reference

2 October 2018

metastatic melanoma

1 reference

physically interacts with

2 October 2018

programmed cell death 1

subject has role

reaction inhibitor

1 reference

Open Targets Platform

https://platform.opentargets.org/drug/CHEMBL3137343

14 August 2023

reference URL

route of administration

intravenous infusion and defusion

0 references

LiverTox likelihood score

LiverTox toxicity likelihood category E*

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Pembrolizumab

1 May 2016

1 reference

Pembrolizumab (English)

DrugBank

immunological antineoplastic agent

17 November 2015

1 reference

Medical Subject Headings

15 March 2018

1 reference

Pembrolizumab (English)

publication date

17 November 2015

Identifiers

1 reference

imported from Wikimedia project

Pembrolizumab (English)

publication date

17 November 2015

PubChem CID

254741536

1 reference

Russian Wikipedia

Wikimedia import URL

https://ru.wikipedia.org/?oldid=107323917

PubChem Substance ID (SID)

0 references

1 reference

Hazardous Substances Data Bank

Pembrolizumab (English)

19 January 2016

1 reference

28 October 2019

PEMBROLIZUMAB (English)

10 May 2021

0 references

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.234.370

27 December 2018

ECHA Substance Infocard ID

[Name confidential or not available] (English)

quotation

CAS no.: 1374853-91-4 (English)

100.234.370

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.234.370

27 December 2018

Guide to Pharmacology Ligand ID

[Name confidential or not available] (English)

quotation

CAS no.: 1374853-91-4 (English)

1 reference

0 references

pembrolizumab

1 reference

Medical Subject Headings

14 March 2018

1 reference

26 February 2018

0 references

1 reference

PEMBROLIZUMAB (English)

MedlinePlus drug identifier

19 January 2016

0 references

1 reference

PEMBROLIZUMAB (English)

19 January 2016

1 reference

Pembrolizumab (English)

electronic Essential Medicines List medicine ID

19 January 2016

565

0 references

Freebase ID

/m/0tkhdkd

0 references

Microsoft Academic ID

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

Quora topic ID

Pembrolizumab

0 references

UK Parliament thesaurus ID

494877

subject named as

Pembrolizumab

2 references

YSO-Wikidata mapping project

UK Parliament thesaurus

9 March 2022

0 references

0 references

1 reference